» Articles » PMID: 1921314

Why Modification of the LD50 Test Will Not Be Enough

Overview
Journal Lab Anim
Date 1991 Jul 1
PMID 1921314
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

During the last 10 years, the 'Three Rs' (reduction, refinement and replacement) concept of alternatives has come to be widely accepted, and new national and international laws require that non-animal procedures should replace animal experimentation wherever possible. Some reduction and refinement of animal use in toxicity testing has been achieved, and non-animal methods are becoming widely used as prescreens. However, even replacing the LD50 test by a modified and validated animal test, the Fixed Dose Procedure, will be a major achievement. In this paper it is argued that this is not good enough, and that more effort must be put into the development, validation, acceptance and use of genuine replacement alternative tests.

Citing Articles

PredAOT: a computational framework for prediction of acute oral toxicity based on multiple random forest models.

Ryu J, Jang W, Jang J, Oh K BMC Bioinformatics. 2023; 24(1):66.

PMID: 36829107 PMC: 9951537. DOI: 10.1186/s12859-023-05176-5.


SAR and QSAR modeling of a large collection of LD rat acute oral toxicity data.

Gadaleta D, Vukovic K, Toma C, Lavado G, Karmaus A, Mansouri K J Cheminform. 2021; 11(1):58.

PMID: 33430989 PMC: 6717335. DOI: 10.1186/s13321-019-0383-2.


Pathway-based predictive approaches for non-animal assessment of acute inhalation toxicity.

Clippinger A, Allen D, Behrsing H, BeruBe K, Bolger M, Casey W Toxicol In Vitro. 2018; 52:131-145.

PMID: 29908304 PMC: 6760245. DOI: 10.1016/j.tiv.2018.06.009.


Prediction of acute mammalian toxicity using QSAR methods: a case study of sulfur mustard and its breakdown products.

Ruiz P, Begluitti G, Tincher T, Wheeler J, Mumtaz M Molecules. 2012; 17(8):8982-9001.

PMID: 22842643 PMC: 6269063. DOI: 10.3390/molecules17088982.


Preclinical toxicology and tissue platinum distribution of novel oral antitumour platinum complexes: ammine/amine platinum(IV) dicarboxylates.

McKeage M, Morgan S, Boxall F, Murrer B, Hard G, HARRAP K Cancer Chemother Pharmacol. 1994; 33(6):497-503.

PMID: 8137461 DOI: 10.1007/BF00686508.